{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:07:11Z","timestamp":1786997231930,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","so-online.net","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.suronc.2016.05.020","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T03:27:16Z","timestamp":1463974036000},"page":"205-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sentinel node biopsy in patients with primary cutaneous melanoma of any thickness: A cost-effectiveness analysis"],"prefix":"10.1016","volume":"25","author":[{"given":"Patricia","family":"Serra-Arbeloa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel Orlando","family":"Rabines-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Soledad","family":"\u00c1lvarez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Guill\u00e9n-Grima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2016.05.020_bib1","unstructured":"Surveillance Epidemiology and End Results (SEER) Program. SEER Stat Fact Sheets: Melanoma of the skin. www.seer.cancer.gov. (Accessed 23.02.2015)."},{"key":"10.1016\/j.suronc.2016.05.020_bib2","series-title":"GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]","author":"Ferlay","year":"2013"},{"key":"10.1016\/j.suronc.2016.05.020_bib3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch. Surg."},{"key":"10.1016\/j.suronc.2016.05.020_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00259-009-1228-4","article-title":"EANM-EORTC general recommendations for sentinel node diagnostics in melanoma","volume":"36","author":"Chakera","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.suronc.2016.05.020_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.12687","article-title":"Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review","volume":"170","author":"Fong","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.suronc.2016.05.020_bib6","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.suronc.2016.05.020_bib7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.suronc.2016.05.020_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.suronc.2016.05.020_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ssu.10020","article-title":"New TNM melanoma staging system: linking biology and natural history to clinical outcomes","volume":"21","author":"Balch","year":"2003","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.suronc.2016.05.020_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0039-6060(03)00275-7","article-title":"Cost-effectiveness of sentinel lymph node biopsy in thin melanomas","volume":"134","author":"Agnese","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2016.05.020_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1245\/s10434-008-0164-z","article-title":"The cost-effectiveness of sentinel node biopsy in patients with intermediate thickness primary cutaneous melanoma","volume":"16","author":"Morton","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.suronc.2016.05.020_bib12","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.suronc.2016.05.020_bib13","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.suronc.2016.05.020_bib14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.sla.0000090446.63327.40","article-title":"Thin melanomas: predictive lethal characteristics from a 30-year clinical experience","volume":"238","author":"Kalady","year":"2003","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2016.05.020_bib15","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","article-title":"Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma","volume":"31","author":"Han","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.suronc.2016.05.020_bib16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","article-title":"Sentinel node biopsy for early-stage melanoma - accuracy and morbidity in MSLT-I, an international multicenter trial","volume":"242","author":"Morton","year":"2005","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2016.05.020_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archdermatol.2010.340","article-title":"Melanoma quality of life: pilot study using utility measurements","volume":"147","author":"King","year":"2011","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.suronc.2016.05.020_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/bjc.2012.62","article-title":"Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis","volume":"106","author":"Verry","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.suronc.2016.05.020_bib19","first-page":"8343","volume":"71","author":"Bolet\u00edn Oficial de Navarra (BON)","year":"2010"},{"key":"10.1016\/j.suronc.2016.05.020_bib20","series-title":"Orden 629\/2009","author":"Bolet\u00edn Oficial de la Comunidad de Madrid (BOCM)","year":"2009"},{"key":"10.1016\/j.suronc.2016.05.020_bib21","article-title":"Comit\u00e9 de Evaluaci\u00f3n de Nuevos Medicamentos de Uso Hospitalario","volume":"No 23","author":"Osakidetza","year":"2012","journal-title":"Inf. Eval."},{"key":"10.1016\/j.suronc.2016.05.020_bib22","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Melanoma (version 2.2015). http:\/\/www.nccn.org. (Accessed 28.02.2015)."},{"key":"10.1016\/j.suronc.2016.05.020_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hec.4730030505","article-title":"Costs, effects and C\/E-ratios alongside a clinical trial","volume":"3","author":"van Hout","year":"1994","journal-title":"Health Econ."},{"key":"10.1016\/j.suronc.2016.05.020_bib24","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.1997.03540480031025","article-title":"The negative side of cost-effectiveness analysis","volume":"277","author":"Stinnett","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.suronc.2016.05.020_bib25","first-page":"334","article-title":"What is an efficient health technology in Spain?","volume":"16","author":"Sacristan","year":"2002","journal-title":"Gac. Sanit."},{"key":"10.1016\/j.suronc.2016.05.020_bib26","first-page":"473","article-title":"How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations","volume":"146","author":"Laupacis","year":"1992","journal-title":"CMAJ"},{"key":"10.1016\/j.suronc.2016.05.020_bib27","first-page":"927","article-title":"Tentative guidelines for using clinical and economic evaluations revisited","volume":"148","author":"Laupacis","year":"1993","journal-title":"CMAJ"},{"key":"10.1016\/j.suronc.2016.05.020_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold","volume":"8","author":"Grosse","year":"2008","journal-title":"Expert Rev. Pharmacoecon Outcomes Res."},{"key":"10.1016\/j.suronc.2016.05.020_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness-the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.suronc.2016.05.020_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1245\/s10434-009-0858-x","article-title":"Factors associated with false-negative sentinel lymph node biopsy in melanoma patients","volume":"17","author":"Scoggins","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.suronc.2016.05.020_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/SLA.0000000000000500","article-title":"Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution","volume":"260","author":"van der Ploeg","year":"2014","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2016.05.020_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bjps.2009.01.027","article-title":"Concerns relating to the conduct and statistical analysis of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in patients with melanoma","volume":"62","author":"Thomas","year":"2009","journal-title":"J.\u00a0Plast. Reconstr. Aesthet. Surg."},{"key":"10.1016\/j.suronc.2016.05.020_bib33","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMc1402989","article-title":"Sentinel-node biopsy in melanoma","volume":"370","author":"Thomas","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.suronc.2016.05.020_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jso.20415","article-title":"Sentinel lymph node biopsy in thin melanoma patients","volume":"93","author":"Hershko","year":"2006","journal-title":"J.\u00a0Surg. Oncol."},{"key":"10.1016\/j.suronc.2016.05.020_bib35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/2012.jama.11030","article-title":"Association between sentinel lymph node excision with or without preoperative SPECT\/CT and metastatic node detection and disease-free survival in melanoma","volume":"308","author":"Stoffels","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.suronc.2016.05.020_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1096-9098(199804)67:4<228::AID-JSO4>3.0.CO;2-A","article-title":"Factors affecting survival following local, regional, or distant recurrence from localized melanoma","volume":"67","author":"Soong","year":"1998","journal-title":"J.\u00a0Surg. Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740416300391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740416300391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T18:24:57Z","timestamp":1656527097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740416300391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0960740416300391"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2016.05.020","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel node biopsy in patients with primary cutaneous melanoma of any thickness: A cost-effectiveness analysis","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2016.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}